Clik here to view.
RECELL® Study in Facial Burns Shows Excellent Cosmetic Outcomes
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today results from a clinical study highlighting the potential benefits of the RECELL® Autologous Cell...
View ArticleClik here to view.
Patient Safety Movement Foundation Supports the Tokyo Declaration on Patient...
IRVINE, Calif. The Patient Safety Movement Foundation (PSMF) announced its support for the Tokyo Declaration on Patient Safety, which was put forward by Japan, Germany, and the United Kingdom at the...
View ArticleClik here to view.
RECELL® Pivotal Trial in Third-Degree Burns Meets Co-Primary Endpoints and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that its pivotal, controlled clinical trial in the treatment of deep full-thickness (third-degree)...
View ArticleClik here to view.
Clik here to view.
患者安全运动基金会支持《患者安全东京宣言》
加州尔湾 (美国商业资讯) — 患者安全运动基金会(PSMF)宣布支持《患者安全东京宣言》，该宣言由日本、德国和英国在2018年4月13-14日于日本东京召开的第三届全球患者安全部长级峰会上提出。该宣言敦促各国加快迈向增进全球患者安全的进程，方法是通过步调一致的激励机制、增加透明度、落实各项惯例，这些惯例认可医疗保健安全和品质不断改进的重要性。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
新研究调查Masimo SpHb®在术后红细胞(RBC)输血最佳实践中的功用
葡萄牙里斯本 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了患者血象管理、止血和栓塞促进网络(NATA) 2018年度年会上呈报的一份摘要中的发现，该研究的研究人员调查了Masimo无创连续血红蛋白(SpHb®)作为术后患者血象管理(PBM)的一部分在支持和提升红细胞(RBC)输血最佳实践中的功用1。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Clik here to view.
joimax® Launches Its Latest Interlaminar Endoscopic System, iLESSYS® Pro, and...
IRVINE, Calif. joimax® again launches new product innovations at the upcoming American Association of Neurological Surgeons (AANS) taking place in New Orleans from April 28 – May 2, and at the...
View ArticleClik here to view.
Aroa Biosurgery and Hydrofera Team up in US
MANCHESTER, Conn. & AUCKLAND, New Zealand New Zealand biomedical company Aroa Biosurgery and United States medical products company Hydrofera are launching Appulse in North America. The two...
View ArticleClik here to view.
Avedro宣布融资2500万美元用于推动创新和商业增长
马萨诸塞州沃尔瑟姆 (美国商业资讯) — 眼科药品和医疗器械公司、角膜重塑领域的世界领先者Avedro, Inc.今天宣布已争取到2500万美元的融资，该融资由Lilly Asia Ventures (LAV)领投，主要跟投者来自于现有的投资者OrbiMed Advisors、InterWest Partners和HealthQuest...
View ArticleClik here to view.
Masimo SpHb®による連続的・非侵襲的ヘモグロビン測定が不必要な輸血を減らすことの有用性および経済的影響を検討する新研究
マドリード （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は、マシモの非侵襲的かつ連続的なヘモグロビン測定値（SpHb®）の有用性に関して最近公表された研究の知見について発表しました。この研究は、不必要な輸血を減らして、経費を削減し、医療の質を改善する上で、SpHb®の有用性を評価したものです1。...
View ArticleClik here to view.
新研究调查Masimo SpHb®连续无创血红蛋白测定在减少不必要输血方面的经济影响和功用
马德里 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了一项近期发表的研究的结果，该研究中，研究人员评估了Masimo 无创连续血红蛋白(SpHb®)在减少不必要输血的次数、从而降低成本、提高医护品质方面的功用1。 该研究中，ETSII-西班牙国立远程教育大学(UNED) HM医院和圣保罗大学(CEU San Pablo...
View ArticleClik here to view.
Clik here to view.
Cerveau Technologies, Inc.与日本东京都老人综合研究所签订研究协议
波士顿 — (美国商业资讯) — Cerveau Technologies Inc.今天宣布与日本东京都老人综合研究所(Tokyo Metropolitan Institute of...
View ArticleClik here to view.
AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that results from a study validating the predicted outcomes and costs from an acute burns health...
View ArticleClik here to view.
Samsung Bioepis Announces Results of Additional One-Year Follow-up Study on...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced additional one-year follow-up study results on SB3, a biosimilar candidate referencing Herceptin® 1 (trastuzumab). The data was made...
View ArticleClik here to view.
AtriCure and Baheal Group Establish Partnership and China Distribution Agreement
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has partnered with...
View ArticleClik here to view.
新研究调查增加补液量期间Masimo SpHb®连续无创血红蛋白测量反映实时医源性血液稀释的功用
丹麦哥本哈根 (美国商业资讯) — Masimo (NASDAQ:MASI)今天发布了Euroanaesthesia 2018上呈报的一篇摘要结果，该研究中，研究人员比较了大手术患者增加补液量期间Masimo无创连续血红蛋白(SpHb®)与间歇性侵入性实验室血红蛋白(LabHb)对医源性血液稀释的反映1。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
AVITA Medical Announces Institutional Placement of A$16.0 Million to Support...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns,...
View ArticleClik here to view.
Masimo SpHb®による連続的・非侵襲的ヘモグロビン測定が輸液逐次投与中の医原性血液希釈をリアルタイムに反映することの有用性を検討する新研究
デンマーク・コペンハーゲン （ビジネスワイヤ） — マシモ（NASDAQ:MASI）は本日、2018年欧州麻酔学会議（Euroanaesthesia...
View Article